BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21810380)

  • 1. Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis.
    Cece H; Yazgan P; Karakas E; Karakas O; Demirkol A; Toru I; Aksoy N
    Clin Invest Med; 2011 Aug; 34(4):E225. PubMed ID: 21810380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endothelial function in patients with ankylosing spondylitis.
    Sari I; Okan T; Akar S; Cece H; Altay C; Secil M; Birlik M; Onen F; Akkoc N
    Rheumatology (Oxford); 2006 Mar; 45(3):283-6. PubMed ID: 16204374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
    Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
    Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial adipose tissue thickness as a new risk factor for atherosclerosis in patients with ankylosing spondylitis.
    Surucu GD; Yildirim A; Yetisgin A; Akturk E
    J Back Musculoskelet Rehabil; 2019; 32(2):237-243. PubMed ID: 30248026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis.
    Gupta N; Saigal R; Goyal L; Agrawal A; Bhargava R; Agrawal A
    Int J Rheumatol; 2014; 2014():839135. PubMed ID: 24803936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls.
    Choe JY; Lee MY; Rheem I; Rhee MY; Park SH; Kim SK
    Joint Bone Spine; 2008 Oct; 75(5):548-53. PubMed ID: 18487068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.
    Akbas HS; Basyigit S; Suleymanlar I; Kemaloglu D; Koc S; Davran F; Demir I; Suleymanlar G
    Lipids Health Dis; 2010 Aug; 9():92. PubMed ID: 20804546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial adipose tissue thickness in patients with ankylosing spondylitis.
    Resorlu H; Akbal A; Resorlu M; Gokmen F; Ates C; Uysal F; Adam G; Aylanc N; Arslan M; İnceer BS
    Clin Rheumatol; 2015 Feb; 34(2):295-9. PubMed ID: 24647981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis.
    Aydoğan Baykara R; Küçük A; Tuzcu A; Tuzcu G; Cüre E; Uslu AU; Omma A
    Turk J Med Sci; 2021 Aug; 51(4):1865-1874. PubMed ID: 33754654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
    Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
    Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension.
    Chen X; Wu Y; Liu L; Su Y; Peng Y; Jiang L; Liu X; Huang D
    Clin Exp Hypertens; 2010 Jan; 32(1):13-20. PubMed ID: 20144068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.
    Olama SM; Elarman MM
    Rheumatol Int; 2013 Jun; 33(6):1487-94. PubMed ID: 23239038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis].
    Salaffi F; Stancati A; Silvestri A; Carotti M; Grassi W
    Reumatismo; 2005; 57(3):161-73. PubMed ID: 16258600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of subclinical vascular disease associated with ankylosing spondylitis.
    Bodnár N; Kerekes G; Seres I; Paragh G; Kappelmayer J; Némethné ZG; Szegedi G; Shoenfeld Y; Sipka S; Soltész P; Szekanecz Z; Szántó S
    J Rheumatol; 2011 Apr; 38(4):723-9. PubMed ID: 21239756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Subclinical Carotid Atherosclerosis and Vitamin D Deficiency in Egyptian Ankylosing Spondylitis Patients.
    Fotoh DS; Serag DM; Badr IT; Saif DS
    Arch Rheumatol; 2020 Sep; 35(3):335-342. PubMed ID: 33458656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase-1 and oxidative status in common Mediterranean β-thalassaemia mutations trait, and their relations to atherosclerosis.
    Labib HA; Etewa RL; Gaber OA; Atfy M; Mostafa TM; Barsoum I
    J Clin Pathol; 2011 May; 64(5):437-42. PubMed ID: 21427447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis.
    Peters MJ; van Eijk IC; Smulders YM; Serne E; Dijkmans BA; van der Horst-Bruinsma IE; Nurmohamed MT
    J Rheumatol; 2010 Jan; 37(1):161-6. PubMed ID: 19955053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
    Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
    Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.